Why This Is the Right Comparison
When searching for the most affordable compounded semaglutide or tirzepatide in 2026, two names consistently appear at the top: the NewSelf program and GobyMeds. Both undercut mainstream providers (Ro Body, Hims, Henry Meds) by $100–$200+/month. This comparison examines every dimension that matters for a safe, effective GLP-1 program decision.
| Feature | NewSelf | GobyMeds |
|---|---|---|
| Semaglutide/Month | $99.97–$134.99 | ~$189 est. |
| Tirzepatide/Month | $144.49–$224.99 | ~$249 est. |
| Membership Fee | None | None |
| Dose Upcharge | None | Varies |
| Overnight Shipping | Free (Mon–Thu) | Free shipping |
| Third-Party Testing | Weekly (all batches) | Varies by pharmacy |
| FDA Warning Letter | Feb 2026 — labeling | None confirmed |
| 3-Month Commitment | Yes — strict cancellation | Varies |
| Trustpilot Rating | 4.5 Excellent | Limited public data |
⚡ Limited Time: Free Overnight Shipping
NewSelf offers the lowest published price for both semaglutide and tirzepatide. Start your free clinical visit today.
✓ All dosages same price · ✓ Full refund if declined · ✓ No membership fees
Pricing: Who Is Actually Cheaper?
At the promotional rate, NewSelf's compounded GLP-1 ($99.97/mo semaglutide, $144.49/mo tirzepatide) publishes lower prices than GobyMeds' estimated range. However, two qualifiers apply: (1) NewSelf's promotional price must be confirmed at checkout — the standard homepage rate is higher ($134.99/$224.99). (2) NewSelf's 3-month minimum commitment with complex cancellation creates higher total cost risk if you need to exit early. Always verify both programs' checkout prices and commitment terms directly before paying. See our complete NewSelf cost guide.
Regulatory Track Record
This is where GobyMeds has a meaningful edge. the NewSelf platform received an FDA warning letter in February 2026 for misleading labeling claims. GobyMeds has no confirmed public FDA warning letter as of September 2026. For patients where regulatory compliance is the primary decision criterion, GobyMeds is the more conservative choice. Read our FDA warning explainer.
Who Should Choose NewSelf
- Price is the primary criterion — especially for tirzepatide ($144 vs ~$249)
- You confirm the promotional checkout price before paying
- You accept the 3-month commitment with full awareness of cancellation terms
- Documented third-party weekly batch testing matters to you
Who Should Consider GobyMeds
- Regulatory clean record is your primary criterion
- You want greater commitment flexibility and lower early-exit risk
- You are uncertain about long-term adherence